Company Executives

$ZVSA Management Team

Mr. Stephen Glover

Chairman of the Board

President

Chief Executive Officer

Co-Founder

Age 65

Compensation $550.0K USD

Sex Male

Mr. Peter Wolfe

Chief Financial Officer

Secretary

Age 57

Compensation $395.0K USD

Sex Male

Ms. Karen Cashmere

Chief Commercial Officer

Age 73

Compensation $486.7K USD

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Stephen Glover Chairman of the Board President Chief Executive Officer Co-Founder	65	$550.0K USD	Male
Mr. Peter Wolfe Chief Financial Officer Secretary	57	$395.0K USD	Male
Ms. Karen Cashmere Chief Commercial Officer	73	$486.7K USD	Female

Board of Directors

From the proxy statement filed Apr 17, 2025

Directors

serving now

Independent

0 of 1

stated in the proxy; 4 not stated

Average tenure

2.5 years

from year joined

CEO also chairs the board

Yes

Stephen C. Glover

Director	Age	On board	Independent	Committees	Other public boards	2024 pay
Stephen C. Glover Board chair, CEO	65	Not stated	Not independent	None stated	PDS Biotechnology	Paid as CEO
Robert G. Finizio	54	2022 3 years	Not stated	None stated	None stated	$63,000
Gregory Freitag	63	2023 2 years	Not stated	Audit · Chair	PDS Biotechnology Corporation	$62,500
Min Chul Park	43	2022 3 years	Not stated	None stated	None stated	$51,500
James Sapirstein	63	2023 2 years	Not stated	None stated	Onconetix, Inc	$63,500

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

We could not read related-party transactions reliably

Rather than show a list that might be incomplete, we show nothing. They are in the proxy filed Apr 17, 2025, in its related person transactions section.

Read them in the proxy

Comments